Overview

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Orophar

Status:
Unknown status

Trial end date:
2018-11-01

Target enrollment:

Participant gender:

Summary

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenges USP, 10 mg (Roxane Laboratories Inc., USA) in patients with oropharyngeal candidiasis, where this condition has been diagnosed by clinical examination and confirmed by fungal culture

Phase:

Phase 3

Details

Lead Sponsor:

Thinq Pharma-CRO Pte. Ltd.

Collaborators:

THINQ Pharma CRO Ltd.
Unique Pharmaceuticals Ltd, India